EUVIMEDOpdag EUVIMED
Crossref

Amplifying the Antitumor Effect of STING Agonist MSA-2 by Phospholipid Nanoparticles Delivering STING mRNA and Copper-Modified MSA-2 Combination

Peng Zhou iD, Mo Wang, Tian He, Ya Cai, Yuhang Zhang, Guishuan Wang, Fei Sun, Guoqi Song, Wenqing Li iD

ACS Applied Materials & Interfaces · 2025-04-30 · 17 (17) · 24820-24829

DOI: 10.1021/acsami.4c21183 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, published online on 2025-04-16. Written by Peng Zhou and 8 co-authors. Institution: Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong 226000, China. Major MEDLINE topics: Copper, Membrane Proteins, Nanoparticles, RNA, Messenger. Cited 5 times so far (Crossref); 43 references. Funded by: National Key Research and Development Program of China, Nantong University, Jiangsu Specially Appointed Professors Program.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

STING activation is a promising application therapeutic strategy for cancer immunotherapy. In particular, MSA-2 as an oral STING agonist is discovered to have antitumor activity. However, how to improve the antitumor effect of MSA-2 is a very valuable contribution to cancer immunotherapy. Here, we use two strategies to amplify the antitumor effect of MSA-2 by phospholipid nanoparticles delivering STING mRNA and copper-modified MSA-2. We synthesized a new series of ionizable phospholipid nanoparticles and optimized a phospholipid nanoparticle (1AP24) for delivering STING mRNA, increasing the expression of STING protein to bind more MSA-2. Second, we synthesized copper-modified MSA-2 (MSA-2-Cu), which induced cell death by Cu2+ toxicity. Combining 1AP24@STING mRNA and MSA-2-Cu can crucially decrease tumor growth and increase a mouse's survival. It is a new treatment strategy through amplifying the STING pathway.

Subjects

MeSH terms (MEDLINE)

CopperMembrane ProteinsNanoparticlesRNA, MessengerPhospholipidsAntineoplastic AgentsAnimalsMiceHumansCell Line, TumorNeoplasmsFemaleSTING Protein

Author keywords

MSA-2STING agonistimmunotherapymRNA deliveryphospholipid nanoparticlesstimulator of interferon genes (STING)

Substances

CopperMembrane ProteinsRNA, MessengerPhospholipidsAntineoplastic AgentsSTING1 protein, humanSTING Protein

Authors and institutions

  • Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong 226000, China.
  • Department of Hematology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226000, Jiangsu China.

ORCID profiles: Peng Zhou, Wenqing Li

Funding

  • National Key Research and Development Program of China
  • Nantong University
  • Jiangsu Specially Appointed Professors Program
  • Jiangsu innovative and entrepreneurial talent

Cite

APA

Zhou, P., Wang, M., He, T., Cai, Y., Zhang, Y., Wang, G., Sun, F., Song, G., & Li, W. (2025). Amplifying the Antitumor Effect of STING Agonist MSA-2 by Phospholipid Nanoparticles Delivering STING mRNA and Copper-Modified MSA-2 Combination. ACS Applied Materials & Interfaces, 17(17), 24820-24829. https://doi.org/10.1021/acsami.4c21183

Vancouver

Zhou P, Wang M, He T, Cai Y, Zhang Y, Wang G, et al. Amplifying the Antitumor Effect of STING Agonist MSA-2 by Phospholipid Nanoparticles Delivering STING mRNA and Copper-Modified MSA-2 Combination. ACS Applied Materials & Interfaces. 2025;17(17):24820-24829. doi:10.1021/acsami.4c21183

BibTeX
@article{Zhou2025,
  author = {Zhou, Peng and Wang, Mo and He, Tian and Cai, Ya and Zhang, Yuhang and Wang, Guishuan and Sun, Fei and Song, Guoqi and Li, Wenqing},
  title = {Amplifying the Antitumor Effect of STING Agonist MSA-2 by Phospholipid Nanoparticles Delivering STING mRNA and Copper-Modified MSA-2 Combination},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  volume = {17},
  number = {17},
  pages = {24820--24829},
  doi = {10.1021/acsami.4c21183}
}
Start for free →